Creatine Monohydrate: Evidence, Research Doses and Product Specs

Creatine monohydrate has an unusually mature evidence base for a sports supplement.

That makes it useful for a different kind of product analysis. The question is not simply whether a tub contains “creatine.” The useful questions are what form it contains, how much is supplied per serving, whether other active ingredients complicate the dose, what the product costs per gram, and whether testing claims can actually be verified.

What creatine monohydrate actually is

Creatine helps replenish phosphocreatine, which contributes to rapid ATP regeneration during short-duration, high-intensity muscular work.

The body synthesizes creatine, and dietary creatine is also present in animal foods. Supplementation increases intake beyond normal dietary exposure and can increase the creatine available within skeletal muscle.

For product comparison, the important point is simpler: creatine monohydrate is the reference form against which other supplemental forms should be judged.

NIH’s Office of Dietary Supplements describes monohydrate as the most widely used and studied form and notes that alternative forms have not been shown to outperform it for increasing muscle creatine, stability, digestibility or safety.

Loading is a research protocol, not a requirement for every user

Creatine studies commonly use two approaches.

One uses a short loading phase followed by a lower maintenance intake. Another uses a smaller daily amount for several weeks without loading.

The difference matters when reading studies because the protocol changes how quickly muscle creatine stores are increased. It should not be converted into individualized dosing advice without considering the person and context.

For Bextera’s purposes, research dosage is therefore stored separately from product serving size.

A product’s scoop size tells us what the manufacturer sells. It does not tell us what every study used.

Performance evidence is strongest for repeated high-intensity work

Creatine’s strongest performance case is not “more energy” in the broad marketing sense.

The better-supported use cases involve repeated short-duration, high-intensity efforts: resistance exercise, repeated maximal contractions, sprint-type activity and training that depends on recovering between hard efforts.

Recent meta-analytic evidence also supports an additional effect on strength when supplementation is combined with resistance training.

That does not mean every strength outcome in every population improves by the same amount. Age, sex, training status, program design, duration and outcome measurement can all influence the observed effect.

Body composition requires more careful wording

Creatine is frequently marketed as a muscle-building supplement, but that phrase compresses several different measurements into one claim.

A 2024 meta-analysis of resistance-training studies reported a greater increase in lean body mass in the creatine groups than with resistance training alone.

Lean body mass, however, is not identical to newly created contractile muscle tissue. Creatine also changes body water, particularly early in supplementation.

That is why Bextera will distinguish lean-body-mass findings from direct measures of muscle hypertrophy rather than treating the terms as interchangeable.

Creatine is not an all-purpose endurance supplement

The evidence pattern changes when exercise depends primarily on continuous endurance rather than repeated high-intensity work.

NIH’s evidence summary describes creatine as having little direct value for endurance sports.

That distinction is useful because generic supplement pages often combine very different exercise outcomes under a single “performance” heading.

Kidney-function claims need context

Creatine can increase serum creatinine because creatinine is a breakdown product related to creatine metabolism.

That matters because serum creatinine is also commonly used when estimating kidney function.

Recent systematic reviews therefore distinguish a change in serum creatinine from evidence of kidney injury. A 2026 meta-analysis found an increase in serum creatinine but no significant difference in urea or estimated glomerular filtration rate between creatine and control groups.

The authors also called for longer randomized trials, particularly beyond one year.

That is a more accurate summary than either saying creatine “damages the kidneys” or claiming that kidney considerations can simply be ignored.

The product label should answer six questions

Before Bextera compares one creatine product with another, we want to know:

1. Is the active ingredient actually creatine monohydrate?
2. How many grams of creatine are supplied per serving?
3. How many servings are in the container?
4. Are other active ingredients included?
5. What does the product cost per gram of creatine?
6. Is any third-party testing claim independently verifiable?

Those fields give us a reproducible comparison framework.

They also make it much harder for package size, scoop size or marketing terminology to substitute for the actual specification.

What we will not score

Bextera will not automatically award a product a higher score because it says “micronized,” “advanced,” “premium,” or uses a proprietary name.

A feature needs to produce a meaningful, verifiable difference before it belongs in a comparison model.

The same rule applies to testing claims. “Third-party tested” is not treated as equivalent to an independently accessible test or certification record.